Molecular and Cellular Advances in Gynecologic Cancer Research
Submission Deadline: 30 Sep 2023
Guest Editor
Special Issue Information
Dear Colleagues,
Gynecologic cancer can occur in any of a woman’s reproductive organs. The increasing incidence and mortality rates due to gynecologic cancers make it essential to understand the molecular and cellular biology of this specific cancer cell. With the advantages of rapidly developing molecular biology technologies, it is critical to explore and study the intricacies of a gynecologic cancer cell. This special issue aims to present recent research on the molecular and cellular advances in gynecologic cancer research that can assist in diagnosis, prognosis, and targeted therapies. We welcome all articles contributing to increasing the knowledge in this field.
Assoc. Prof. Padmanaban S. Suresh
Guest Editor
Keywords
- ovarian cancer
- endometrial cancer
- cervical cancer
- vulvar cancer
- vaginal cancer
- molecular pathology
- biomarkers
- cell biology
- genetics
- genomics
- proteomics
Published Papers (4)
SPARC is a Novel Prognostic Biomarker for Ovarian Cancer and Associated with Immune Signatures and Drug Response
Clin. Exp. Obstet. Gynecol. 2024, 51(3), 61; https://doi.org/10.31083/j.ceog5103061
(This article belongs to the Special Issue Molecular and Cellular Advances in Gynecologic Cancer Research)
The Mechanism and Dynamic Regulation of Epithelial to Mesenchymal Transition in Ovarian Cancer
Clin. Exp. Obstet. Gynecol. 2023, 50(12), 272; https://doi.org/10.31083/j.ceog5012272
(This article belongs to the Special Issue Molecular and Cellular Advances in Gynecologic Cancer Research)
AFF3 is a Prognostic Biomarker Correlated with Immune Infiltrates in Triple-Negative Breast Cancer
Clin. Exp. Obstet. Gynecol. 2023, 50(8), 165; https://doi.org/10.31083/j.ceog5008165
(This article belongs to the Special Issue Molecular and Cellular Advances in Gynecologic Cancer Research)
Molecular and Cellular Advances in Gynecologic Cancer Research
Clin. Exp. Obstet. Gynecol. 2023, 50(6), 122; https://doi.org/10.31083/j.ceog5006122
(This article belongs to the Special Issue Molecular and Cellular Advances in Gynecologic Cancer Research)
